|
Trial Details
Thank you so much for the info. We still don't know if the Sapacitabine trial is right for us, but your description is very interesting. The Estybon trial at NIH (2 hours away) required 8 days inpatient out of every 14, so one visit a week sounds easy!
__________________
Alice, wife of John, diagnosed MDS RAEB-1 5/10. Tried Vidaza, ON 01910.Na (at NIH), & Vidaza + Revlimid with no effect. Progressed to RAEB-2. Supportive care only from 9/2011 until death 1/26/12.
|